BEGIN:VCALENDAR
VERSION:2.0
PRODID:-//Science in Boston - ECPv6.17.3//NONSGML v1.0//EN
CALSCALE:GREGORIAN
METHOD:PUBLISH
X-ORIGINAL-URL:https://scienceinboston.com
X-WR-CALDESC:Events for Science in Boston
REFRESH-INTERVAL;VALUE=DURATION:PT1H
X-Robots-Tag:noindex
X-PUBLISHED-TTL:PT1H
BEGIN:VTIMEZONE
TZID:America/Vancouver
BEGIN:DAYLIGHT
TZOFFSETFROM:-0800
TZOFFSETTO:-0700
TZNAME:PDT
DTSTART:20230312T100000
END:DAYLIGHT
BEGIN:STANDARD
TZOFFSETFROM:-0700
TZOFFSETTO:-0800
TZNAME:PST
DTSTART:20231105T090000
END:STANDARD
BEGIN:DAYLIGHT
TZOFFSETFROM:-0800
TZOFFSETTO:-0700
TZNAME:PDT
DTSTART:20240310T100000
END:DAYLIGHT
BEGIN:STANDARD
TZOFFSETFROM:-0700
TZOFFSETTO:-0800
TZNAME:PST
DTSTART:20241103T090000
END:STANDARD
BEGIN:DAYLIGHT
TZOFFSETFROM:-0800
TZOFFSETTO:-0700
TZNAME:PDT
DTSTART:20250309T100000
END:DAYLIGHT
BEGIN:STANDARD
TZOFFSETFROM:-0700
TZOFFSETTO:-0800
TZNAME:PST
DTSTART:20251102T090000
END:STANDARD
END:VTIMEZONE
BEGIN:VEVENT
DTSTART;TZID=America/Vancouver:20240319T080000
DTEND;TZID=America/Vancouver:20240321T170000
DTSTAMP:20231117T181217Z
CREATED:20231117T181217Z
LAST-MODIFIED:20231117T181217Z
UID:28043-1710835200-1711040400@scienceinboston.com
SUMMARY:6th CKD Drug Development Summit 2024
DESCRIPTION:Advance More Personalized Therapies for Rare & Common Kidney Diseases The surge of clinical breakthroughs in SGLT2s\, GLP-1s and ERAs for CKD\, significant advancements to strengthen proteinuria and GFR slope as surrogates for long-term outcomes\, and a wave of promising new targets in development\, has truly lit the fuse on decades of innovative kidney research. Bringing together 200+ biopharma stakeholders\, from scientific research to clinical development and outcomes\, across three days of concentrated discussion\, the 6th CKD Drug Development Summit is the definitive forum for KOLs\, industry experts\, and regulators to concentrate kidney innovation onto the next generation of drug development. From uncovering the genetic architecture of specific CKD subgroups and revolutionizing translatable models of renal pathophysiology\, to breaking new ground in CKD trial design and implementing new therapies into the treatment paradigm\, join Novo Nordisk\, Boehringer Ingelheim\, Eli Lilly\, AstraZeneca\, the FDA\, Regeneron\, Novartis and more to collaborate and drive progress of precision medicine and reinvent the landscape of rare and common kidney disease treatments.
URL:https://scienceinboston.com/event/6th-ckd-drug-development-summit-2024/
LOCATION:Hiliton Boston Back Bay\, 40 Dalton Street\, Boston\, MA\, 02115\, United States
ATTACH;FMTTYPE=image/jpeg:https://scienceinboston.com/wp-content/uploads/sites/6/2023/11/Screenshot-2023-11-10-124327.jpg
END:VEVENT
BEGIN:VEVENT
DTSTART;TZID=America/Vancouver:20240320T120000
DTEND;TZID=America/Vancouver:20240320T130000
DTSTAMP:20240220T182117Z
CREATED:20240220T182117Z
LAST-MODIFIED:20240220T182117Z
UID:29060-1710936000-1710939600@scienceinboston.com
SUMMARY:Closing Out Your Research: Managing Data Transfer Between Collaborators
DESCRIPTION:Knowledge transfer refers to sharing or disseminating knowledge and providing inputs to problem-solving. When employees leave\, they take their skills and institutional knowledge with them. Capturing their knowledge and research outputs is essential to the success of future users. \nThis session will present the knowledge transfer process and what to document at the point of employee offboarding. We will explore how individuals collect\, organize\, access\, store and share project data in order to facilitate reuse and ongoing project work. \nInstructors: Julie Goldman\, Research Data Services Librarian\, Countway Library\nSarah Marchese\, Senior Research Data Management Analyst\, HMS Research Computing
URL:https://scienceinboston.com/event/closing-out-your-research-managing-data-transfer-between-collaborators/
LOCATION:Online
END:VEVENT
END:VCALENDAR